About Stabilux Biosciences
Stabilux Biosciences is a company based in Houghton Lake (United States) founded in 2014. The company has 14 employees as of December 31, 2021. Stabilux Biosciences operates in a competitive market with competitors including NuProbe, Nanosphere, Sirigen, ATDBio and Marker Gene Technologies, among others.
- Headquarter Houghton Lake, United States
- Employees 14 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Stabilux Biosciences Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$256 K (USD), Grant
Sep 15, 2020
-
Investors
SBIR
& 2 more
-
Employee Count
14
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Stabilux Biosciences
Unlock access to complete
Funding Insights of Stabilux Biosciences
Investors in Stabilux Biosciences
Stabilux Biosciences has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include SBIR, America’s Seed Fund and Invest Michigan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund backed by the US Government
|
Locked | Locked | Locked | |
|
Investments are provided to early-stage technology startups in Michigan.
|
Locked | Locked | Locked | |
|
Federal innovation and scientific achievement services are provided.
|
Locked | Locked | Locked |
Investor details for Stabilux Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Stabilux Biosciences
Investment portfolio details for Stabilux Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Stabilux Biosciences
Detailed financials for Stabilux Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Stabilux Biosciences Comparisons
Peer comparison for Stabilux Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Stabilux Biosciences
Stabilux Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NuProbe, Nanosphere, Sirigen, ATDBio and Marker Gene Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Sensitive multiplex platforms for QPCR are developed using toehold probes.
|
|
| Locked | Locked | Locked |
Diagnostic tests for personalized medicine targeting infections are provided.
|
|
| Locked | Locked | Locked |
High sensitivity fluorescence detection technologies for diagnostics and life science applications
|
|
| Locked | Locked | Locked |
Developer of oligonucleotides
|
|
| Locked | Locked | Locked |
Develops kits and reagents for research application
|
|
| Locked | Locked | Locked |
Non-enzymatic nucleic acid detection technology is developed using DGL probes.
|
Detailed competitors of Stabilux Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Stabilux Biosciences
Complete news archive for Stabilux Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stabilux Biosciences
Stabilux Biosciences was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Stabilux Biosciences is headquartered in Houghton Lake, United States. It is registered at Houghton Lake, Michigan, United States.
As of Dec 31, 2021, the latest employee count at Stabilux Biosciences is 14.
Stabilux Biosciences was founded in 2014 and is based in Houghton Lake, United States. Operations focus on the biotechnology sector, where proprietary fluorophores are created to enhance flow cytometry reagents. These fluorophores are designed for compatibility across cytometer channels, with features including adjustable brightness, straightforward antibody conjugation, photostability, support for multiple colors, and solubility in water for stability.
Stabilux Biosciences's top competitors include NuProbe, Nanosphere and Sirigen.
Stabilux Biosciences has 3 investors. Key investors include SBIR, America’s Seed Fund, and Invest Michigan.